Key facts
- Notable investors include IDG Capital, Guanghua Kaiyuan Capital, Chengdu Venture Capital, Kangyu Capital, Womeda Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ChipBio
- ·The full record, as it builds
Funding rounds
No funding rounds for ChipBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ChipBio
Developer of derived medical products designed for regenerative medicine. The company develops several class III implantable medical devices which can be used in the fields of plastic and cosmetic surgery, urology, orthopedics, ophthalmology, and stomatology, providing patients with more possibilities in the field of tissue or organ repair and replacement.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2016
- Website
- chipbio.cn/
- Ownership
- Privately Held (backing)
ChipBio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ChipBio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ChipBio in its N-PORT filings yet. We sweep new filings monthly.